Irinotecan is a compound used as an active pharmaceutical ingredient in the manufacturing of anti-cancer medications. It is primarily applied in research and production settings for formulations targeting colon cancer and small cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 97682-44-5
Irinotecan hydrochloride
pharmaceutical raw material
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Lappaconitine hydrobromide
pharmaceutical raw material
Ractopamine
pharmaceutical raw material
Raclopride c-11
pharmaceutical raw material
Ciprofloxacin lactate
pharmaceutical raw material
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate
UWKQSNNFCGGAFS-XIFFEERXSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7